99mTc-MDP as an imaging tool to evaluate the in vivo biodistribution of solid lipid nanoparticles

Appl Radiat Isot. 2018 Nov:141:51-56. doi: 10.1016/j.apradiso.2018.08.015. Epub 2018 Aug 22.

Abstract

The aim of this study was to establish the in vivo uptake and tissue distribution of 99mTc-MDP-encapsulated Solid Lipid Nanoparticles (SLNs) post administration. Radioactive 99mTc-MDP encapsulated into SLNs was administered to rats to trace their biodistribution through imaging and ex vivo studies. As expected IV injected 99mTc-MDP exhibited predominant visual bone uptake and a high localisation of particles in the kidneys (3.87%ID/g) followed by bone (2.66%ID/g). IV administered 99mTc-MDP encapsulated by SLN showed similar uptake than 99mTc-MDP. Orally administrated 99mTc-MDP showed no uptake in any organs except the GI-tract while orally administered 99mTc-MDP-SLN showed distinct transfer of 99mTc-MDP from the GI tract with measurable levels in the kidneys and bone.

Keywords: (99m)Tc-MDP; Biodistribution; In vivo imaging; SLNs.

MeSH terms

  • Administration, Oral
  • Animals
  • Bone and Bones / diagnostic imaging
  • Bone and Bones / metabolism
  • Drug Delivery Systems
  • Female
  • Injections, Intravenous
  • Kidney / diagnostic imaging
  • Kidney / metabolism
  • Lipids / administration & dosage
  • Lipids / chemistry*
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Nanotechnology
  • Particle Size
  • Radionuclide Imaging
  • Radiopharmaceuticals / administration & dosage
  • Radiopharmaceuticals / pharmacokinetics*
  • Rats
  • Rats, Sprague-Dawley
  • Technetium Tc 99m Medronate / administration & dosage
  • Technetium Tc 99m Medronate / pharmacokinetics*
  • Tissue Distribution

Substances

  • Lipids
  • Radiopharmaceuticals
  • Technetium Tc 99m Medronate